Efficacy, Safety, Tolerability, and Biomarkers of Ibudilast (MN-166) in Patients Hospitalized With COVID-19 at Risk for ARDS

Clinical trial NCT04429555 · COMPLETED

Trial details

NCT number: NCT04429555
Sponsor: MediciNova
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pneumonia, Viral

Start date: 2021-01-11
Primary completion: 2022-06-30
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.